BioMoti Company
BioMoti seeks to transform the treatment of cancer by targeted delivery of therapeutics to the intracellular space of cancer cells
Estimated Revenue:
Less than $1M
Funding Status:
Seed
Industry:
PharmTech
Number Of Exists:
N/A
Technology:
Small Molecules
Founded Date:
2006
Investor Type:
N/A
Headquarters:
London, England, United Kingdom
Employee Number:
1-10
Investment Stage:
N/A